about
Nanoparticle-Based Antimicrobials: Surface Functionality is CriticalHighly stable noble metal nanoparticles dispersible in biocompatible solvents: synthesis of cationic phosphonium gold nanoparticles in water and DMSO.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsStimuli-responsive nanomaterials for therapeutic protein delivery.A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal TherapyPhotoresponsive nanoparticles for drug delivery.Soft Supramolecular Nanoparticles by Noncovalent and Host-Guest Interactions.Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.Updates on smart polymeric carrier systems for protein delivery.Self-folded redox/acid dual-responsive nanocarriers for anticancer drug delivery.GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancersMetal-Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer CellsHydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.Development of a molecular bioswitch using fluorescence lifetime imaging: Incremental activation of fluorescein diacetate.Multifunctional quantum dots and liposome complexes in drug delivery.Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.Cytotoxicity of Postmodified Zeolitic Imidazolate Framework-90 (ZIF-90) Nanocrystals: Correlation between Functionality and Toxicity.Highly sensitive capillary electrophoretic immunoassay of rheumatoid factor in human serum with gold nanoparticles enhanced chemiluminescence detection.
P2860
Q26752437-52DBFEBC-83AD-42FF-88D3-3A85AFF3041BQ31038938-519A0CDF-D90E-4A9B-854A-56151A12A619Q33855309-944B5EDD-4726-4B38-877F-41A0205C047CQ35088244-FBA17F7D-E4E3-4F7E-B78E-C6AE79D95103Q35686257-A90D8128-BF77-4BA7-BE0F-51D154705609Q36346590-440346B7-3198-4938-BF45-D6722191681BQ38638661-89FC9E77-1643-45AB-AD2E-6AD24D340C15Q38770152-AF5D6B99-33DE-4B95-BF3D-9EFDF9938966Q39351089-307D108B-6ED9-4084-BDD4-AE707A619EE4Q40469273-5C73E9E6-615B-4C1F-BA63-0BAAB50DE10AQ41385956-A0DC7F3B-06B2-4B96-B255-1A4896ADFB65Q42859704-98C4547D-215E-4F12-A5A4-A050A91FD480Q47881774-C88B6F66-F4A2-408B-A1F2-0BDCBB72A3C2Q47932897-FF1F063E-5CCE-4301-AFB3-C7E83AA4600AQ48672044-9436D837-1D36-4787-8B33-455456F488EBQ48675906-FCAD16D4-6227-49E1-B631-A06B7F4C34EEQ51566051-E6A523BC-C4E5-4EB1-B7ED-64ED2DA29D00Q53655052-35CFD717-4FC5-4303-8286-A8B62888D3BE
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Triggered Nanoparticles as Therapeutics.
@en
type
label
Triggered Nanoparticles as Therapeutics.
@en
prefLabel
Triggered Nanoparticles as Therapeutics.
@en
P2860
P1433
P1476
Triggered Nanoparticles as Therapeutics
@en
P2093
Brian Creran
Chang Soo Kim
P2860
P304
P356
10.1016/J.NANTOD.2013.07.004
P577
2013-08-01T00:00:00Z